Items where Author is "Abhari, A. P."

Article

(2022) Does COVID-19 increase the long-term relapsing-remitting multiple sclerosis clinical activity? A cohort study. BMC NEUROLOGY. ISSN 1471-2377 J9 - BMC NEUROL

(2022) Multiple sclerosis disease-modifying therapies and COVID-19 vaccines: a practical review and meta-analysis. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. pp. 986-994. ISSN 0022-3050 1468-330X J9 - J NEUROL NEUROSUR PS

(2022) N-Methyl-D-Aspartate (NMDA)-Type Glutamate Receptors and Demyelinating Disorders: A Neuroimmune Perspective. Mini Rev Med Chem. ISSN 1389-5575

(2022) Self-Reported safety of the BBIBP-CorV (Sinopharm) COVID-19 vaccine among Iranian people with multiple sclerosis. HUMAN VACCINES & IMMUNOTHERAPEUTICS. ISSN 2164-5515 2164-554X J9 - HUM VACC IMMUNOTHER

(2021) COVID-19 and the Risk of Relapse in Multiple Sclerosis Patients: A Fight with No Bystander Effect? Multiple Sclerosis and Related Disorders. ISSN 2211-0348

(2021) Epidemiological and clinical features of pediatric-onset multiple sclerosis: A population-based study in Isfahan, Iran, between 1997-2020. CURRENT JOURNAL OF NEUROLOGY. pp. 222-228. ISSN 2717-011X J9 - CURR J NEUROL

(2021) MRI signs of CNS demyelinating diseases. Multiple Sclerosis and Related Disorders. ISSN 2211-0348

(2021) "NMDA receptor spectrum disorder" in the differential diagnosis of demyelinating disorders of the CNS: optic neuritis and myelitis. Neurological Sciences. pp. 151-157. ISSN 1590-1874

(2021) Prediabetes and COVID-19 severity, an underestimated risk factor: A systematic review and meta-analysis. DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS. ISSN 1871-4021 1878-0334 J9 - DIABETES METAB SYND